Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up

Radiotherapy and Oncology

Volumn 51, Issue 1, 1999, Pages 35-42

  Reinders, Janny G ^a   Heijmen, Ben J M ^a   Olofsen van Acht, Manouk J J ^a   Van Putten, Wim L J ^a   Levendag, Peter C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Heart disease; Hodgkin's disease; Late toxicity; Radiotherapy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CHILD; CORONARY RISK; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION INJURY; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, HIGH-ENERGY; RISK;

EID: 0033026864     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(99)00026-2     Document Type: Article

References (36)

1. Allavena C., Conroy T., Aletti P., Bey P., Lederlin P. Late cardiopulmonary toxicity after treatment for Hodgkin's disease. Br. J. Cancer. 65:1992;908-912.
2. Applefeld M.M., Slawson R.G., Spicer K.M., Singleton R.T., Wesley M.N., Wiernik P.H. Long-term cardiovascular evaluation of patients with Hodgkin's disease treated by thoracic mantle radiation therapy. Cancer Treat. Rep. 66:1982;1003-1013.
3. Boivin J., Hutchison G.B., Lubin J.H., Mauch P.M. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer. 69:1992;1241-1247.
4. Brincker H., Bentzen S.M. A re-analysis of available dose-response and time-dose data in Hodgkin's disease. Radiother. Oncol. 30:1994;227-230.
5. Brosius F.C.III., Waller B.F., Roberts W.C. Analysis of 16 young (aged 15 to 33) years necropsy patients who received over 3500 rads to the heart. Am. J. Med. 70:1981;519-530.
6. Carmel R.J., Kaplan H.S. Mantle irradiation in Hodgkin's disease: an analysis of technique, tumor eradication, and complications. Cancer. 37:1976;2813-2825.
7. Cosset J.M., Henry-Amar M., Girinski T., Malaise E.P., Dupouy N., Dutreix J. Late toxicity of radiotherapy in Hodgkin's disease: the role of fraction size. Acta Oncol. 27:1988;123-129.
8. Cosset J.M., Henry-Amar M., Meerwaldt J.H. Long-term toxicity of early stages of Hodgkin's disease therapy: the EORTC experience. Ann. Oncol. 2:1991;77-82.
9. Cosset J.M., Henry-Amar M., Pellae-Cosset B., et al. Pericarditis and myocardial infarctions after Hodgkin's disease therapy. Int. J. Radiat. Oncol. Biol. Phys. 21:1991;447-449.
10. Creutzberg C.L., Visser A.G., De Porre P.M.Z.R., Meerwaldt J.H., Althof V.G.M., Levendag P.C. Accuracy of patient positioning in mantle field irradiation. Radiother. Oncol. 23:1992;257-264.
11. Dühmke E., Diehl V., Loeffler M., et al. Randomized trial with early-stage Hodgkin's disease testing 30 Gy vs. 40 Gy extended field radiotherapy alone. Int. J. Radiat. Oncol. Biol. Phys. 36:1996;305-310.
12. Emami B., Lyman J.T., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 21:1991;109-122.
13. Glanzmann C., Huguenin P., Lütolf U.M., Maire R., Jenni R., Gumppenberg V. Cardiac lesions after mediastinal irradiation for Hodgkin's disease. Radiother. Oncol. 30:1994;43-54.
14. Gottdiener J.S., Katin M.J., Borer J.S., Bacharach S.L., Green M.V. Late cardiac effects of therapeutic mediastinal irradiation. New Engl. J. Med. 308:1983;569-572.
15. Green D.M., Gingell R.L., Pearce J., Panahon A.M., Ghoorah J. The effect of mediastinal irradiation on cardiac function of patients treated during childhood and adolescence for Hodgkin's disease. J. Clin. Oncol. 5:1987;239-245.
16. Gustavsson A., Eskilsson J., Landberg T., et al. Late cardiac effects after mantle radiotherapy in patients with Hodgkin's disease. Ann. Oncol. 1:1990;355-363.
17. Hancock S.L., Donaldson S.S., Hoppe R.T. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J. Clin. Oncol. 11:1993;1208-1215.
18. Hancock S.L., Hoppe R.T., Horning S.J., Rosenberg S.A. Intercurrent death after Hodgkin's disease therapy in radiotherapy and adjuvant MOPP trials. Ann. Intern. Med. 109:1988;183-189.
19. Hancock S.L., Tucker M.A., Hoppe R.T. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. J. Am. Med. Assoc. 270:1993;1949-1955.
20. Henry-Amar M., Hayat M., Meerwaldt J.H., et al. Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. Int. J. Radiat. Oncol. Biol. Phys. 19:1990;1155-1157.
21. Hoppe R.T. Long-term complications of treatment for Hodgkin's disease. Trends Onco-Hematol. 4:1996;46-48.
22. King V., Constine L.S., Clark D., et al. Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease. Int. J. Radiat. Oncol. Biol. Phys. 36:1996;881-889.
23. King V., Constine L.S., Clark D., Schwartz R.G., Muhs A.G., Rubin P. Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease. Int. J. Radiat. Oncol. Biol. Phys. 27:1993;233 abstract.
24. Kreuser E., Völler H., Behles C., et al. Evaluation of late cardiotoxicity with pulsed Doppler echocardiography in patients treated for Hodgkin's disease. Br. J. Haematol. 84:1993;615-622.
25. Lederman G.S., Sheldon T.A., Chaffey J.T., Herman T.S., Gelman R.S., Coleman C.N. Cardiac disease after mediastinal irradiation for seminoma. Cancer. 60:1987;772-776.
26. Mauch P.M., Kalish L.A., Marcus K.C. Long-term survival in Hodgkin's disease: relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J. Sci. Am. 1:1995;33-42.
27. Maunoury C., Pierga J.Y., Valette H., Tchernia G., Cosset J.M., Desgrez A. Myocardial perfusion damage after mediastinal irradiation for Hodgkin's disease: a thallium-201 single photon emission tomography study. Eur. J. Nucl. Med. 19:1992;871-873.
28. Mefferd J.M., Donaldson S.S., Link M.P. Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy. Int. J. Radiat. Oncol. Biol. Phys. 16:1989;679-685.
29. Morgan G.W., Freeman A.P., McLean R.G., Jarvie B.H., Giles R.W. Late cardiac, thyroid, and pulmonary sequelae of mantle radiotherapy for Hodgkin's disease. Int. J. Radiat. Oncol. Biol. Phys. 11:1985;1925-1931.
30. Orzan F., Brusca A., Conte M.R., Presbitero P., Figliomeni M.C. Severe coronary artery disease after radiation therapy of the chest and mediastinum: clinical presentation and treatment. Br. Heart J. 69:1993;496-500.
31. Pierce R.H., Hafermann M.D., Kagan A.R. Changes in the transverse cardiac diameter following mediastinal irradiation for Hodgkin's disease. Radiology. 93:1969;619-624.
32. Pohjola-Sintonen S., Tötterman K., Salmo M., Siltanen P. Late cardiac effects of mediastinal radiotherapy in patients with Hodgkin's disease. Cancer. 60:1987;31-37.
33. Savage D.E., Constine L.S., Schwartz R.G., Rubin P. Radiation effects on left ventricular function and myocardial perfusion in long term survivors of Hodgkin's disease. Int. J. Radiat. Oncol. Biol. Phys. 19:1990;721-727.
34. Stevens R.E., Levy J.M., Steinfeld A.D. Symptomatic heart disease after mediastinal irradiation for testicular seminoma. Int. J. Radiat. Oncol. Biol. Phys. 27:1993;218 abstract.
35. Tarbell N.J., Thompson L., Mauch P.M. Thoracic irradiation in Hodgkin's disease: disease control and long-term complications. Int. J. Radiat. Oncol. Biol. Phys. 18:1990;275-281.
36. Van Rijswijk R.E.N., Verbeek J., Haanen C., Dekker A.W., Van Daal W.A.J., Van Peperzeel H.A. Major complications and causes of death in patients treated for Hodgkin's disease. J. Clin. Oncol. 5:1987;1624-1633.